Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Neurology|August 2, 2008
Dose comparison trial of sustained-release fampridine in multiple sclerosisA D Goodman, T R Brown, J A Cohen, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|April 1, 1993
Perils and pitfalls of magnetic resonance imaging in the diagnosis of multiple sclerosis. The Rochester-Toronto MRI Study GroupR B Schiffer, D W Giang, A Mushlin, et al.
The American Journal of Clinical Nutrition|April 1, 1992
Nicotine effects on body weight: a regulatory perspectiveS R Schwid, M D Hirvonen, R E Keesey
Journal of Neuroimmunology|May 20, 1998
Interferon-beta-1-b (IFN-B) decreases induced nitric oxide (NO) production by a human astrocytoma cell lineP Guthikonda, J Baker, D H Mattson
Neurology|January 3, 2001
Are quantitative functional measures more sensitive to worsening MS than traditional measures?S R Schwid, A D Goodman, B R Apatoff, et al.
Journal of Neuroimmunology|July 30, 1999
Therapy of relapsing multiple sclerosis. Treatment approaches for nonrespondersJ A Cohen, J L Carter, R P Kinkel, et al.
Oral Surgery, Oral Medicine, and Oral Pathology|July 1, 1977
Eikenella corrodens isolated in oral infections of dental originA D Goodman
Neurology|May 10, 2006
Safety of rasagiline in elderly patients with Parkinson diseaseC G Goetz, S R Schwid, S W Eberly, et al.
Neurology|July 30, 2008
Quantitative risk-benefit analysis of natalizumabJ P Thompson, K Noyes, E R Dorsey, et al.
Pageof 8